<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33218681</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-1497</ISSN><JournalIssue CitedMedium="Internet"><Volume>99</Volume><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Neurobiology of aging</Title><ISOAbbreviation>Neurobiol Aging</ISOAbbreviation></Journal><ArticleTitle>Genetic screening of ANXA11 revealed novel mutations linked to amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>102.e11</StartPage><EndPage>102.e20</EndPage><MedlinePgn>102.e11-102.e20</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neurobiolaging.2020.10.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0197-4580(20)30327-4</ELocationID><Abstract><AbstractText>ANXA11 mutations have previously been discovered in amyotrophic lateral sclerosis (ALS) motor neuron disease. To confirm the contribution of ANXA11 mutations to ALS, a large exome data set obtained from 330 French patients, including 150 familial ALS index cases and 180 sporadic ALS cases, was analyzed, leading to the identification of 3 rare ANXA11 variants in 5 patients. The novel p.L254V variant was associated with early onset sporadic ALS. The novel p.D40Y mutation and the p.G38R variant concerned patients with predominant pyramidal tract involvement and cognitive decline. Neuropathologic findings in a p.G38R carrier associated the presence of ALS typical inclusions within the spinal cord, massive degeneration of the lateral tracts, and type A frontotemporal lobar degeneration. This mutant form of annexin A11 accumulated in various brain regions and in spinal cord motor neurons, although its stability was decreased in patients' lymphoblasts. Because most ANXA11 inclusions were not colocalized with transactive response DNA-binding protein 43 or p62 deposits, ANXA11 aggregation does not seem mandatory to trigger neurodegeneration with additional participants/partner proteins that could intervene.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Teyssou</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muratet</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amador</LastName><ForeName>Maria-Del-Mar</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, Paris, France; D&#xe9;partement de Neurologie, Assistance Publique H&#xf4;pitaux de Paris (APHP), Centre de r&#xe9;f&#xe9;rence SLA Ile de France, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrien</LastName><ForeName>M&#xe9;lanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lautrette</LastName><ForeName>G&#xe9;raldine</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Service de Neurologie, Centre de R&#xe9;f&#xe9;rence SLA et autres maladies du neurone moteur, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machat</LastName><ForeName>Selma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Service de Neurologie, Centre de R&#xe9;f&#xe9;rence SLA et autres maladies du neurone moteur, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boill&#xe9;e</LastName><ForeName>S&#xe9;verine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larmonier</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Banque d'ADN et de cellules du G&#xe9;n&#xe9;thon, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saker</LastName><ForeName>Safaa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Banque d'ADN et de cellules du G&#xe9;n&#xe9;thon, Evry, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leguern</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, Paris, France; D&#xe9;partement de G&#xe9;n&#xe9;tique et Cytog&#xe9;n&#xe9;tique, Unit&#xe9; Fonctionnelle de neurog&#xe9;n&#xe9;tique mol&#xe9;culaire et cellulaire, APHP, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cazeneuve</LastName><ForeName>C&#xe9;cile</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de G&#xe9;n&#xe9;tique et Cytog&#xe9;n&#xe9;tique, Unit&#xe9; Fonctionnelle de neurog&#xe9;n&#xe9;tique mol&#xe9;culaire et cellulaire, APHP, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marie</LastName><ForeName>Yannick</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guegan</LastName><ForeName>Justine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gyorgy</LastName><ForeName>Beata</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cintas</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, Centre de r&#xe9;f&#xe9;rence SLA, CHU de Toulouse, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meininger</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>H&#xf4;pital des Peupliers, Ramsay G&#xe9;n&#xe9;rale de Sant&#xe9;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Forestier</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>D&#xe9;partement de Neurologie, Assistance Publique H&#xf4;pitaux de Paris (APHP), Centre de r&#xe9;f&#xe9;rence SLA Ile de France, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France; D&#xe9;partement de recherche en &#xe9;thique, EA 1610, Etudes des sciences et techniques, Universit&#xe9; Paris Sud/Paris Saclay, Orsay, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salachas</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, Paris, France; D&#xe9;partement de Neurologie, Assistance Publique H&#xf4;pitaux de Paris (APHP), Centre de r&#xe9;f&#xe9;rence SLA Ile de France, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couratier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service de Neurologie, Centre de R&#xe9;f&#xe9;rence SLA et autres maladies du neurone moteur, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camu</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Centre de r&#xe9;f&#xe9;rence SLA, H&#xf4;pital Gui de Chauliac, CHU et Universit&#xe9; de Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seilhean</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, Paris, France; D&#xe9;partement de Neuropathologie, APHP, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millecamps</LastName><ForeName>St&#xe9;phanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle &#xe9;pini&#xe8;re, ICM, Inserm U1127, CNRS UMR7225, Sorbonne Universit&#xe9;, UPMC Univ Paris 6 UMRS1127, Paris, France. Electronic address: stephanie.millecamps@upmc.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurobiol Aging</MedlineTA><NlmUniqueID>8100437</NlmUniqueID><ISSNLinking>0197-4580</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017302">Annexins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017302" MajorTopicYN="N">Annexins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030541" MajorTopicYN="N">Databases, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059472" MajorTopicYN="N">Exome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="N">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="Y">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">ANXA11</Keyword><Keyword MajorTopicYN="N">Annexin A11</Keyword><Keyword MajorTopicYN="N">FALS</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">FTLD</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Neuropathology</Keyword><Keyword MajorTopicYN="N">SALS</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>21</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33218681</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.10.015</ArticleId><ArticleId IdType="pii">S0197-4580(20)30327-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>